Arrowhead Research reported $-29924000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Cerulean Pharma CERU:US $ -9.16M 1.84M
Dicerna Pharmaceuticals DRNA:US $ -40.27M 10.3M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Novartis NOVN:VX SF 4424M 620M
Opko Health OPK:US $ -0.26M 31.96M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Spectrum Pharmaceuticals SPPI:US $ -49.92M 14.24M
Tg Therapeutics TGTX:US $ -78.5M 12.13M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Xencor XNCR:US $ 52.25M 54.74M
YTE INCY:US $ 199.6M 31.06M